HomeExpert Opinions and Interviews:

Expert Opinions and Interviews:

Cancer
Expert Opinions and Interviews:
News
Prevention and Early Detection
Treatment

A qualitative interview research on colorectal most cancers screening in China

Editor - July 2, 2024

1 Introduction The incidence and mortality of colorectal most cancers (CRC) have been vastly decreased by large-scale screening for lesions in colon and...

1...30 3132Page 32 of 32

Hot Topics

Open-Label Extension of Ponsegromab Reveals Efficacy in Most cancers-Related Cachexia

Imfinzi Plus BCG Improves Illness-Free Survival in Excessive-Danger NMIBC

Sevabertinib Efficient in Pretreated and First-Line HER2-Mutant NSCLC

Expert Opinions and Interviews:

Hot Topics

Open-Label Extension of Ponsegromab Reveals Efficacy in Most cancers-Related Cachexia

Imfinzi Plus BCG Improves Illness-Free Survival in Excessive-Danger NMIBC

Sevabertinib Efficient in Pretreated and First-Line HER2-Mutant NSCLC

Quick Links

Must Read

Open-Label Extension of Ponsegromab Reveals Efficacy in Most cancers-Related Cachexia

Imfinzi Plus BCG Improves Illness-Free Survival in Excessive-Danger NMIBC

Sevabertinib Efficient in Pretreated and First-Line HER2-Mutant NSCLC

Supervised Bodily Exercise Does Not Enhance High quality of Life in Metastatic Most cancers

Popular Articles

Open-Label Extension of Ponsegromab Reveals Efficacy in Most cancers-Related Cachexia

Imfinzi Plus BCG Improves Illness-Free Survival in Excessive-Danger NMIBC

Sevabertinib Efficient in Pretreated and First-Line HER2-Mutant NSCLC